# Chongqing Southwest No 2 Pharmaceutical Factory Co., Ltd - Inspection Records

Source: https://www.keypedia.com/companies/chongqing-southwest-no-2-pharmaceutical-factory-co-ltd/dbcf7c68-8b86-427d-90cd-92c27afcb7fa

> Inspection records and compliance data for Chongqing Southwest No 2 Pharmaceutical Factory Co., Ltd in Chongqing, None. Access full analysis and detailed observations.

---

## Details

- Name: Chongqing Southwest No 2 Pharmaceutical Factory Co., Ltd
- FEI Number: 3008857790
- City: Chongqing
- State: None
- Country Name: China
- Address Line 1: Degan Street
- Zip Code: None

## Related Documents

- [FDA Inspection 1243715 - Chongqing Southwest No 2 Pharmaceutical Factory Co., Ltd - 2024-05-31](https://www.keypedia.com/records/fda_inspections/chongqing-southwest-no-2-pharmaceutical-factory-co-ltd/4beff8dd-a276-4a7c-9e73-48ca404cefee) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 31, 2024
- [483 - Chongqing Southwest No 2 Pharmaceutical Factory Co., Ltd - 2024-05-27](https://www.keypedia.com/records/483/chongqing-southwest-no-2-pharmaceutical-factory-co-ltd/32df5e9d-7727-4650-b1e8-70e65c73303c) — source: FDA, date: May 27, 2024
- [FDA Inspection 1021732 - Chongqing Southwest No 2 Pharmaceutical Factory Co., Ltd - 2017-04-28](https://www.keypedia.com/records/fda_inspections/chongqing-southwest-no-2-pharmaceutical-factory-co-ltd/4330cf6e-8453-4f85-b122-5f6257657210) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 28, 2017
- [FDA Inspection 985510 - Chongqing Southwest No 2 Pharmaceutical Factory Co., Ltd - 2016-07-28](https://www.keypedia.com/records/fda_inspections/chongqing-southwest-no-2-pharmaceutical-factory-co-ltd/2bbc4699-a681-4a34-92c1-9cb3b3879896) — classification: No Action Indicated (NAI), source: FDA, date: July 28, 2016
- [FDA Inspection 794375 - Chongqing Southwest No 2 Pharmaceutical Factory Co., Ltd - 2012-07-19](https://www.keypedia.com/records/fda_inspections/chongqing-southwest-no-2-pharmaceutical-factory-co-ltd/1884b835-6aab-4e21-b927-7c83492f3b53) — classification: No Action Indicated (NAI), source: FDA, date: July 19, 2012

## Related Companies

- [Yuki Gosei Kogyo Co., Ltd.](https://www.keypedia.com/companies/yuki-gosei-kogyo-co-ltd/94411f09-2744-47ca-9250-20774e61824e)
- [Cambridge Isotope Laboratories, Inc.](https://www.keypedia.com/companies/cambridge-isotope-laboratories-inc/bb7d8566-a216-469b-88ac-a3fa0060927e)
- [Cayman Chemical Company, Inc.](https://www.keypedia.com/companies/cayman-chemical-company-inc/8a9655d6-3cec-4e6e-836e-17e9659f3e5b)
- [DDP Specialty Electronic Materials US 9, LLC](https://www.keypedia.com/companies/ddp-specialty-electronic-materials-us-9-llc/bfd7705b-0b03-4c4e-a3d7-d0940e04a868)
- [Piramal Pharma Limited](https://www.keypedia.com/companies/piramal-pharma-limited/c2aa1ac8-a474-4948-84c1-cd848c50558e)
- [Shouguang Fukang Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/shouguang-fukang-pharmaceutical-co-ltd/c6836369-cde1-4980-97c8-314af897d7e1)
- [SI Group, Inc.](https://www.keypedia.com/companies/si-group-inc/6f15e9d4-610c-474c-907b-9d9d3b5621f3)
- [ISP Sutton Laboratories](https://www.keypedia.com/companies/isp-sutton-laboratories/27126d09-6823-4e2b-8f31-d8645861af12)
- [Herbamed AG](https://www.keypedia.com/companies/herbamed-ag/d4987d1a-9073-4e45-ba78-0c4fe49241ef)
- [Zaklady Farmaceutyczne Polpharma S.A.](https://www.keypedia.com/companies/zaklady-farmaceutyczne-polpharma-sa/f59abed7-7196-4b5f-ae0e-3286e2e8de39)

## Related Officers

- [Dorothy P. Kramer](https://www.keypedia.com/people/dorothy-p-kramer/12e3c8b6-6359-43cc-96fd-ba2097225e3d)
- [investigator](https://www.keypedia.com/people/marian-e-ramirez/4b718b67-fee0-488c-9354-ee366d3510ad)